Single cell transcriptome analysis of TIL for gene expression and TCR immunoprofiling in the renal cell carcinoma
Single-cell RNA-seq · human · 30 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 30 samples: 30 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Tumor-reactive TCRs within exhausted TILs reveal cancer type-specific immune landscapes in renal cell carcinomaFrontiers in immunology · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE304262_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1291848 and SRA study SRP604431. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 30 sample titles: 30 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9146349 KID-001_T_cell_for_GEX, stage I RCC
- GSM9146350 KID-002_T_cell_for_GEX, stage I RCC
- GSM9146351 KID-004_T_cell_for_GEX, stage III RCC
- GSM9146352 KID-005_T_cell_for_GEX, stage IV RCC
- GSM9146353 KID-006_T_cell_for_GEX, stage III RCC
- GSM9146354 KID-007_T_cell_for_GEX, stage IV RCC
- GSM9146355 KID-009_T_cell_for_GEX, stageIV RCC
- GSM9146356 KID-010_T_cell_for_GEX, stage III RCC
- GSM9146357 KID-011_T_cell_for_GEX, stage III RCC
- GSM9146358 KID-012_T_cell_for_GEX, stage I RCC
- GSM9146359 KID-013_T_cell_for_GEX, stage III RCC
- GSM9146360 KID-014_T_cell_for_GEX, stage III RCC
- GSM9146361 KID-015_T_cell_for_GEX, stage III RCC
- GSM9146362 KID-016_T_cell_for_GEX, stage I RCC
- GSM9146363 KID-018_T_cell_for_GEX, stage I RCC
- GSM9146364 KID-001_T_cell_for_TCR, stage I RCC
- GSM9146365 KID-002_T_cell_for_TCR, stage I RCC
- GSM9146366 KID-004_T_cell_for_TCR, stage III RCC
- GSM9146367 KID-005_T_cell_for_TCR, stage IV RCC
- GSM9146368 KID-006_T_cell_for_TCR, stage III RCC
- GSM9146369 KID-007_T_cell_for_TCR, stage IV RCC
- GSM9146370 KID-009_T_cell_for_TCR, stageIV RCC
- GSM9146371 KID-010_T_cell_for_TCR, stage III RCC
- GSM9146372 KID-011_T_cell_for_TCR, stage III RCC
- GSM9146373 KID-012_T_cell_for_TCR, stage I RCC
- GSM9146374 KID-013_T_cell_for_TCR, stage III RCC
- GSM9146375 KID-014_T_cell_for_TCR, stage III RCC
- GSM9146376 KID-015_T_cell_for_TCR, stage III RCC
- GSM9146377 KID-016_T_cell_for_TCR, stage I RCC
- GSM9146378 KID-018_T_cell_for_TCR, stage I RCC
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing · shares renal
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing · shares renal
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares renal
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing · shares renal
- GSE19982 Gene expression discriminates chromophobe renal cell carcinoma and oncocytoma 30 samples same disease briefing · shares renal
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing · shares renal
- GSE214635 The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis 18 samples same disease briefing
- GSE223688 SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents 6 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.